MktsMarkets

Oncolytics Biotech Inc.
NASDAQ: ONCYKey statistics
ONCY News
Stories mentioning ONCY from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q1 '25Mar 31 |
|---|---|---|
| Income Statement | ||
| Revenue | ||
| Cost of Goods Sold | ||
| Gross Profit | 0.00 | 0.00 |
| Operating Expenses | ||
| Research & Development | 4,552 | 2,800 |
| Sales General & Admin | ||
| Total Operating Expenses | 9,281 | 5,021 |
| Operating Income (Loss) | (9,281) | (5,021) |
| Interest Income | 44.00 | 117.00 |
| Interest Expense | ||
| Other Expense | 38.00 | 310.00 |
| Pretax Income | ||
| Tax Provision | ||
| Net Income (Loss) | (9,243) | (4,711) |
| Earnings Per Share (Basic) | (0.08) | (0.06) |
| Earnings Per Share (Diluted) | (0.08) | (0.06) |
| Weighted Average Shares Outstanding (Basic) | 112,293 | 84,631 |
| Weighted Average Shares Outstanding (Diluted) | 112,293 | 84,631 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ONCY
Oncolytics Biotech Inc. (NASDAQ: ONCY) is a stock listed on the Nasdaq Stock Market under the ticker symbol ONCY. It last traded at $0.4400 (Oct 29, 2026, 9:31 AM ET), down 1.0% on the day. That gives Oncolytics Biotech a market capitalisation of $94.2M.
Over the past 52 weeks ONCY has traded between $1.48 and $4.49.
For the quarter ended Mar 31, 2026 it reported a net loss of $9.2M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$9.2M |
| Mar 31, 2025 | — | -$4.7M |
From Oncolytics Biotech’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…